DekaBank Deutsche Girozentrale Increases Stock Position in UnitedHealth Group Inc (NYSE:UNH)

Share on StockTwits

DekaBank Deutsche Girozentrale boosted its stake in UnitedHealth Group Inc (NYSE:UNH) by 19.9% in the second quarter, Holdings Channel.com reports. The fund owned 544,440 shares of the healthcare conglomerate’s stock after buying an additional 90,376 shares during the quarter. UnitedHealth Group comprises about 0.7% of DekaBank Deutsche Girozentrale’s portfolio, making the stock its 25th largest holding. DekaBank Deutsche Girozentrale’s holdings in UnitedHealth Group were worth $134,546,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. Norges Bank purchased a new stake in UnitedHealth Group in the fourth quarter valued at $2,343,175,000. Thoroughbred Financial Services LLC lifted its position in UnitedHealth Group by 25,321.4% in the second quarter. Thoroughbred Financial Services LLC now owns 1,922,872 shares of the healthcare conglomerate’s stock valued at $192,287,000 after acquiring an additional 1,915,308 shares during the last quarter. Sanders Capital LLC lifted its position in UnitedHealth Group by 50.2% in the second quarter. Sanders Capital LLC now owns 4,626,666 shares of the healthcare conglomerate’s stock valued at $1,255,689,000 after acquiring an additional 1,546,140 shares during the last quarter. FMR LLC lifted its position in UnitedHealth Group by 1.9% in the fourth quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock valued at $16,063,258,000 after acquiring an additional 1,232,189 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in UnitedHealth Group by 9.1% in the fourth quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after acquiring an additional 965,763 shares during the last quarter. 85.65% of the stock is owned by hedge funds and other institutional investors.

In other news, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction on Tuesday, June 11th. The shares were sold at an average price of $248.00, for a total value of $2,480,000.00. Following the transaction, the director now owns 187,663 shares of the company’s stock, valued at approximately $46,540,424. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $246.40, for a total transaction of $1,232,000.00. Following the completion of the transaction, the director now directly owns 187,979 shares in the company, valued at approximately $46,318,025.60. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 37,000 shares of company stock worth $9,195,620. 0.82% of the stock is currently owned by insiders.

Shares of UNH opened at $249.22 on Wednesday. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $235.62 billion, a P/E ratio of 19.35, a price-to-earnings-growth ratio of 1.33 and a beta of 0.61. The firm’s 50 day moving average price is $251.38. UnitedHealth Group Inc has a 1 year low of $208.07 and a 1 year high of $287.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.46 by $0.14. The business had revenue of $60.60 billion for the quarter, compared to the consensus estimate of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The company’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.14 earnings per share. As a group, equities research analysts expect that UnitedHealth Group Inc will post 14.82 earnings per share for the current fiscal year.

UNH has been the subject of a number of research reports. Barclays reduced their price target on shares of UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a research report on Wednesday, April 17th. Cantor Fitzgerald set a $310.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Royal Bank of Canada set a $311.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. SunTrust Banks reduced their target price on shares of UnitedHealth Group to $300.00 and set a “buy” rating for the company in a report on Wednesday, April 17th. They noted that the move was a valuation call. Finally, Bank of America reaffirmed a “buy” rating and issued a $290.00 target price (down from $320.00) on shares of UnitedHealth Group in a report on Wednesday, April 17th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $295.06.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: How is the Producer Price Index calculated?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Recent Analysts’ Ratings Changes for Sanmina
Recent Analysts’ Ratings Changes for Sanmina
Recent Research Analysts’ Ratings Changes for Avid Bioservices
Recent Research Analysts’ Ratings Changes for Avid Bioservices
Research Analysts’ Weekly Ratings Updates for American National BankShares
Research Analysts’ Weekly Ratings Updates for American National BankShares
Karpus Management Inc. Has $23.32 Million Holdings in ISHARES TR/CORE DIVID GR ETF
Karpus Management Inc. Has $23.32 Million Holdings in ISHARES TR/CORE DIVID GR ETF
STRATA Skin Sciences  Receives “Buy” Rating from HC Wainwright
STRATA Skin Sciences Receives “Buy” Rating from HC Wainwright
First Internet Bancorp  Announces $0.06 Quarterly Dividend
First Internet Bancorp Announces $0.06 Quarterly Dividend


© 2006-2019 Ticker Report